Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients
Related Experiment Videos
D C Goff1, A W Brotman, M Waites
1Erich Lindemann Mental Health Center, Massachusetts General Hospital, Boston.
The American Journal of Psychiatry
|April 1, 1990
Abstract:
Mean ratings of positive and negative symptoms and depression significantly improved in nine treatment-resistant schizophrenic patients who completed a 6-week open trial of fluoxetine added to their neuroleptics. The authors identify differences between responders and nonresponders and recommend controlled trials.